Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?

Background/Aims: Cardiovascular calcification contributes to the increased mortality in hemodialysis patients. Sclerostin was identified as an antianabolic bone factor causing soft tissue calcification. Data on prospective large-scale studies associating sclerostin with mortality in hemodialysis pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Albina Nowak (Author), Ferruh Artunc (Author), Andreas L. Serra (Author), Emily Pollock (Author), Pierre-Alexandre Krayenbühl (Author), Christian Müller (Author), Björn Friedrich (Author)
Format: Book
Published: Karger Publishers, 2015-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available